White Paper: Oncology Care in a Value-Based World
Over the past decade, the emergence of targeted therapies, immunotherapeutics, and cellular and gene therapies have transformed the oncology treatment landscape. While these have demonstrated improved patient outcomes, they come with a high cost which can make it challenging for patients to gain access to these life-saving treatments.
In this white paper, we explore the results of an exclusive Precision Value & Health survey on how payers and providers are adapting to—and supporting—the delivery of value-based care in an evolving oncology landscape.
